Delivery Order SPE2DR25D2101-SPE2DR26F46ET
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,024.38 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on December 8, 2025, with completion scheduled for December 30, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,212.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, competitively awarded contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,096.33 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $7,348.14 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on November 14, 2025, with an ultimate completion date of December 8, 2025. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,028.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The award, issued on October 20, 2025, with an ultimate completion date of November 10, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,255.36 to supply Varivax vaccine with diluents. The contract, awarded on October 21, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 12, 2025. This award was made on a competitive basis with no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $49,597.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, designated as a firm fixed-price delivery order, was competitively awarded without set-aside provisions and is scheduled for completion by December 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,059.07 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46ETDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,004.14 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This competitive, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio encompasses vaccines, specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This award reflects AmerisourceBergen's demonstrated capability to meet federal requirements through open competition, with the company positioned as a key supplier within the DLA's Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/3/25 |